Evaluation of Rosuvastatin Therapy on SIRT1 Gene Expression in Patients with Multiple Sclerosis: An Uncontrolled Clinical Trial

BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease. Current medications have some limitations such as low efficacy and high side effects. In recent years, statins have been raised as potential therapeutics for MS treatment with minimal complications. In addition, patient monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Batoee, Shakiba, Etminaniesfahani, Maryam, Mazdeh, Mehrdokht, Soltanian, Alireza, Nouri, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630595/
https://www.ncbi.nlm.nih.gov/pubmed/38021265
http://dx.doi.org/10.1016/j.curtheres.2023.100718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630595/
https://www.ncbi.nlm.nih.gov/pubmed/38021265
http://dx.doi.org/10.1016/j.curtheres.2023.100718

Ejemplares similares